244 related articles for article (PubMed ID: 18599795)
1. Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers.
Pepper C; Lin TT; Pratt G; Hewamana S; Brennan P; Hiller L; Hills R; Ward R; Starczynski J; Austen B; Hooper L; Stankovic T; Fegan C
Blood; 2008 Nov; 112(9):3807-17. PubMed ID: 18599795
[TBL] [Abstract][Full Text] [Related]
2. The BH3-only protein Puma plays an essential role in p53-mediated apoptosis of chronic lymphocytic leukemia cells.
Zhu HJ; Liu L; Fan L; Zhang LN; Fang C; Zou ZJ; Li JY; Xu W
Leuk Lymphoma; 2013 Dec; 54(12):2712-9. PubMed ID: 23517560
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of serum levels and cellular expression of adiponectin in B-cell chronic lymphocytic leukemia.
Molica S; Vitelli G; Cutrona G; Todoerti K; Mirabelli R; Digiesi G; Giannarelli D; Sperduti I; Molica M; Gentile M; Morabito F; Neri A; Ferrarini M
Int J Hematol; 2008 Nov; 88(4):374-380. PubMed ID: 18818986
[TBL] [Abstract][Full Text] [Related]
4. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia.
Buhl AM; Jurlander J; Geisler CH; Pedersen LB; Andersen MK; Josefsson P; Petersen JH; Leffers H
Eur J Haematol; 2006 Jun; 76(6):455-64. PubMed ID: 16529606
[TBL] [Abstract][Full Text] [Related]
5. Fludarabine induces apoptosis in chronic lymphocytic leukemia--the role of P53, Bcl-2, Bax, Mcl-1, and Bag-1 proteins.
Faria JR; Yamamoto M; Faria RM; Kerbauy J; Oliveira JS
Braz J Med Biol Res; 2006 Mar; 39(3):327-33. PubMed ID: 16501812
[TBL] [Abstract][Full Text] [Related]
6. Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia.
Stamatopoulos B; Meuleman N; Haibe-Kains B; Duvillier H; Massy M; Martiat P; Bron D; Lagneaux L
Clin Chem; 2007 Oct; 53(10):1757-66. PubMed ID: 17702857
[TBL] [Abstract][Full Text] [Related]
7. CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL.
Majid A; Lin TT; Best G; Fishlock K; Hewamana S; Pratt G; Yallop D; Buggins AG; Wagner S; Kennedy BJ; Miall F; Hills R; Devereux S; Oscier DG; Dyer MJ; Fegan C; Pepper C
Leuk Res; 2011 Jun; 35(6):750-6. PubMed ID: 21093051
[TBL] [Abstract][Full Text] [Related]
8. Long intergenic non-coding RNA-p21 is associated with poor prognosis in chronic lymphocytic leukemia.
Abo Elwafa R; Abd Elrahman A; Ghallab O
Clin Transl Oncol; 2021 Jan; 23(1):92-99. PubMed ID: 32468342
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells.
Podhorecka M; Halicka D; Klimek P; Kowal M; Chocholska S; Dmoszynska A
Ann Hematol; 2010 Nov; 89(11):1115-24. PubMed ID: 20499237
[TBL] [Abstract][Full Text] [Related]
10. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
Johnston JB; Paul JT; Neufeld NJ; Haney N; Kropp DM; Hu X; Cheang M; Gibson SB
Leuk Lymphoma; 2004 Oct; 45(10):2017-27. PubMed ID: 15370246
[TBL] [Abstract][Full Text] [Related]
11. Expression level of DEK in chronic lymphocytic leukemia is regulated by fludarabine and Nutlin-3 depending on p53 status.
Wang DM; Liu L; Fan L; Zou ZJ; Zhang LN; Yang S; Li JY; Xu W
Cancer Biol Ther; 2012 Dec; 13(14):1522-8. PubMed ID: 23052131
[TBL] [Abstract][Full Text] [Related]
12. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia.
Podhorecka M; Halicka D; Klimek P; Kowal M; Chocholska S; Dmoszynska A
Ann Hematol; 2011 Feb; 90(2):173-83. PubMed ID: 20714724
[TBL] [Abstract][Full Text] [Related]
14. MiRNA-Mediated Knock-Down of Bcl-2 and Mcl-1 Increases Fludarabine-Sensitivity in CLL-CII Cells.
Ashofteh N; Amini R; Molaee N; Karami H; Baazm M
Asian Pac J Cancer Prev; 2021 Jul; 22(7):2191-2198. PubMed ID: 34319043
[TBL] [Abstract][Full Text] [Related]
15. Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.
Tromp JM; Geest CR; Breij EC; Elias JA; van Laar J; Luijks DM; Kater AP; Beaumont T; van Oers MH; Eldering E
Clin Cancer Res; 2012 Jan; 18(2):487-98. PubMed ID: 22128299
[TBL] [Abstract][Full Text] [Related]
16. Combined analysis of ZAP-70 and CD38 expression in sudanese patients with B-cell chronic lymphocytic leukemia.
Basabaeen AA; Abdelgader EA; BaHashwan OS; Babekir EA; Abdelateif NM; Bamusa SA; Abdelrahim SO; Altayeb OA; Fadul EA; Ibrahim IK
BMC Res Notes; 2019 May; 12(1):282. PubMed ID: 31122288
[TBL] [Abstract][Full Text] [Related]
17. CD38 Expression and Variation as a Prognostic Factor Chronic Lymphocytic Leukemia.
Falay M; Ceran F; Gunes AK; Dagdas S; Ayli M; Ozet G
Clin Lab; 2016 Jul; 62(7):1287-1293. PubMed ID: 28164634
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide.
Amigo-Jiménez I; Bailón E; Ugarte-Berzal E; Aguilera-Montilla N; García-Marco JA; García-Pardo A
PLoS One; 2014; 9(6):e99993. PubMed ID: 24956101
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells.
Rossi FM; Del Principe MI; Rossi D; Irno Consalvo M; Luciano F; Zucchetto A; Bulian P; Bomben R; Dal Bo M; Fangazio M; Benedetti D; Degan M; Gaidano G; Del Poeta G; Gattei V
J Transl Med; 2010 Mar; 8():23. PubMed ID: 20211015
[TBL] [Abstract][Full Text] [Related]
20. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
